Medication Updates

Industry Targeted Insight


First biosimilar for Humira® now available

Medication Update / Amjevita™


New SGLT2 inhibitor for Diabetes Type 2

Medication Update / Brenzavvy

Jesduvroq 2

New Oral Option for patient with Anemia due to CKD on Dialysis

Medication Update / Jesduvroq

Medication Update_004_Aflibercept

New Biosimilar for Macular Degeneration and Retinopathy

Medication Update / Aflibercept (Eylea)

Need help?

PayerAlly’s mission is to provide pharmacy consulting services to our clients in an impartial manner enabling them to make better decisions, lower overall medication costs, and better plan for future high-cost, life-changing medications.